- Ford Posts Profit After Restructuring; Shares Jump
- 3M Profit Surges Past Estimates; Shares Climb
- AT&T Beats Profit Forecast, Wireless Growth Strong
- McDonald's Profit Falls 8% on Strong Dollar
- UPS Profit Meets Forecasts, but Outlook Is Weak
- Strong Sales Boost Bristol-Myers Profit
- Philip Morris Tops View, Raises Full-Year Guidance
- Credit Suisse Quarterly Net Profit Beats Forecasts
- Obama: Economic Recovery Depends on Healthcare
- Why Options are Hot on This Bleach Maker
- Warren Buffett Cuts Stake in Moody's By Almost 17%
- You Can't Go Wrong With 'Best of Breed' Stocks: Analyst
- eBay May Have Finally Bottomed
- Pitts: New Rx For New FDA Chief
- NASDAQ's Biggest Winners in 11-Day Streak
- Brooklyn Decker Talks iPhone And We Take Photos
- The Power Of The Compliment
- Your Best Tech Stock Plays: Strategists
- IGT 3rd-quarter profit drops on lower demand
- New York Times Co. reports surprising 2Q profit
- Correction: Barnes & Noble electronic bookstore
- S&P puts AMR, UAL on watch, negative outlook
- Aeroflot to delay delivery of 5 Airbus jets
- Allstate to close Miss. center
- Report: Toyota to end Calif. joint venture with GM
- Officials probe Jackson's doctors in star's death
- L-3 Communications reports drop in 2Q profit
MINNEAPOLIS - Medical-device maker Medtronic Inc. said Friday it started a recall of some of its Quick-set infusion sets because the products could deliver an incorrect dose of insulin.
The infusion sets have the reference numbers MMT-396, MMT-397, MMT-398 and MMT-399 with lot numbers beginning with "8." Infusion sets are thin plastic tubes that carry insulin from a pump into the body of a patient. Medtronic said about 60,000 of the tubes may not work properly because they do not allow the insulin pump to properly vent air pressure. That could cause the pump to deliver too much or too little insulin.
The company did not report any injuries or deaths connected to the recalled products.
Most of the infusion sets were distributed in the U.S. Medtronic said patients should stop using a product in the affected lot, and return it to the company. It said it will replace the sets at no charge. Medtronic estimated that the problem could affect about 2 percent of the 3 million infusion sets currently with customers.
The Quick-set devices are used with Medtronic's MiniMed Paradigm insulin pumps, and they are intended to be replaced about once every three days.




